Marché mondial des systèmes d’échographie cardiovasculaire – Tendances et prévisions de l’industrie jusqu’en 2031

Analyse du marché et de la taille des systèmes d'échographie cardiovasculaire

Selon le rapport 2022 de l'American Heart Association (AHA), environ 244,1 millions de personnes dans le monde ont reçu un diagnostic de cardiopathie ischémique (CI) en 2020, l'Afrique du Nord, le Moyen-Orient, l'Asie centrale et du Sud et l'Europe de l'Est connaissant les taux de prévalence les plus élevés. Cette tendance devrait se poursuivre en raison de facteurs de risque répandus tels que l'hypertension , l'obésité, le tabagisme, le diabète et les modes de vie sédentaires. En conséquence, la demande d'échographie pour le diagnostic, la surveillance et le traitement des maladies cardiovasculaires devrait augmenter, ce qui stimulera la croissance du marché des systèmes d'échographie cardiovasculaire tout au long de la période de prévision. Le marché des systèmes d'échographie cardiovasculaire joue un rôle central dans la cardiologie moderne, offrant des capacités de diagnostic et des outils de surveillance essentiels pour les maladies cardiovasculaires dans le monde entier.

Français La taille du marché mondial des systèmes d’échographie cardiovasculaire était évaluée à 1,84 milliard USD en 2023 et devrait atteindre 2,80 milliards USD d’ici 2031, avec un TCAC de 5,37 % au cours de la période de prévision de 2024 à 2031. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l’épidémiologie des patients, l’analyse du pipeline, l’analyse des prix et le cadre réglementaire.

Portée du rapport et segmentation du marché       

Market Definition

A cardiovascular ultrasound system is a medical device used for non-invasive imaging of the heart and surrounding blood vessels. It utilizes high-frequency sound waves (ultrasound) to create real-time images of the heart's anatomy, chambers, valves, and blood flow dynamics. This imaging technology helps healthcare professionals diagnose and monitor various cardiovascular conditions such as heart disease, heart valve disorders, congenital heart defects, and abnormalities in blood circulation.      

Cardiovascular Ultrasound System Market Dynamics

Drivers

• Growing Prevalence of Cardiovascular Diseases  

The increasing prevalence of cardiovascular diseases, encompassing conditions such as heart disease and hypertension, is a significant driver for the cardiovascular ultrasound system market. As these diseases continue to rise globally due to aging populations, sedentary lifestyles, and dietary habits, there is a heightened demand for early diagnosis and continuous monitoring. According to the June 2021 update from the World Health Organization (WHO), cardiovascular diseases (CVDs) remain the primary cause of global mortality, with approximately three-quarters of CVD-related deaths occurring in low- and middle-income countries. Cardiovascular ultrasound systems play a crucial role in this landscape by enabling healthcare providers to detect abnormalities in cardiac function, assess vascular health, and guide treatment decisions. This high mortality underscores an increasing demand for disease diagnostics and monitoring, which is poised to drive growth in the cardiovascular ultrasound system market.

• Technological Advancements in Ultrasound Imaging      

Innovations such as AI-driven algorithms for automated measurements and enhanced imaging quality are revolutionizing diagnostic capabilities. AI facilitates real-time image analysis, enabling faster and more accurate detection of cardiovascular conditions. These advancements not only streamline workflow and enhance diagnostic accuracy but also improve efficiency in clinical settings. For instance, in October 2020, GE Healthcare obtained 510k clearance from the United States Food and Drug Administration for its ultra-edition package of vivid cardiovascular ultrasound systems. This package incorporates new artificial intelligence (AI)-based features designed to enable clinicians to conduct faster and more consistent exams with improved repeatability. By integrating AI with ultrasound systems, healthcare providers can achieve higher diagnostic confidence, optimize treatment planning, and deliver personalized care tailored to individual patient needs, thus driving market growth and adoption.            

• Rising Adoption of Non-Invasive Diagnostic Techniques   

Non-invasive procedures reduce patient discomfort, minimize recovery times, and lower the risk of complications compared to traditional invasive methods. Cardiovascular ultrasound systems play a pivotal role in this shift by offering detailed insights into cardiac structure and function without the need for surgical intervention. This capability not only enhances patient satisfaction but also supports early detection of cardiovascular abnormalities, facilitates timely interventions, and improves overall healthcare outcomes. As healthcare systems prioritize patient safety and comfort, the demand for non-invasive cardiovascular ultrasound systems is expected to continue growing, driving market expansion.

Opportunities

• Development of Next-Generation Cardiovascular Ultrasound Systems   

Continued advancements in AI and machine learning technologies are opening new avenues for the development of next-generation cardiovascular ultrasound systems. AI-powered algorithms enable real-time image analysis, automated measurements, and decision support systems that enhance diagnostic accuracy and clinical workflow efficiency. These technologies hold promise for improving the detection of subtle cardiac abnormalities, predicting disease progression, and optimizing treatment strategies tailored to individual patient profiles. By harnessing the power of AI, manufacturers can innovate advanced ultrasound systems capable of delivering precise diagnostic insights, supporting personalized medicine approaches, and creating new opportunities for the market in cardiovascular care.           

• Personalized Medicine and Point-of-Care Testing     

The growing demand for personalized medicine and point-of-care testing solutions is driving the evolution of handheld and smartphone-integrated ultrasound devices within the cardiovascular ultrasound system market. These compact and portable devices offer flexibility in clinical settings, enabling healthcare providers to perform cardiac evaluations conveniently at the patient's bedside or in remote locations. They cater to the increasing need for rapid diagnostic assessments, early intervention, and personalized treatment plans tailored to individual patient needs. By integrating ultrasound technology with mobile platforms and cloud-based solutions, manufacturers are facilitating seamless data integration, real-time collaboration among healthcare teams, improved patient outcomes, and expanding market opportunities globally.

Restraints/Challenges

• High Cost of Ultrasound Equipment

The high initial cost and ongoing maintenance expenses associated with cardiovascular ultrasound systems pose significant barriers to market penetration, particularly in resource-constrained healthcare settings. The capital investment required for acquiring advanced ultrasound equipment, coupled with expenses for training healthcare staff and maintaining equipment functionality, can strain limited budgets. This financial burden often deters healthcare facilities from investing in new technologies or upgrading existing systems, thereby limiting access to advanced diagnostic capabilities and innovative treatment options for patients.        

• Challenges in Reimbursement Policies

Inconsistent reimbursement policies and varying reimbursement rates for cardiovascular ultrasound procedures across different regions and healthcare systems present challenges for market growth and adoption. Reimbursement complexities can affect healthcare providers' ability to recover costs associated with ultrasound services, impacting their willingness to invest in advanced equipment and integrate new technologies into clinical practice. Lack of uniformity in reimbursement guidelines and delays in reimbursement approvals further hinder market expansion efforts and innovation in cardiovascular ultrasound systems.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In May 2024, Siemens Healthineers introduced advanced AI applications for its Acuson Sequoia ultrasound system, alongside a new 4D transesophageal (TEE) transducer designed for cardiology examinations. Among the new AI-driven cardiology features are AI Measure, which automates the acquisition of essential measurements for routine echocardiography exams, and 2D HeartAI, enhancing efficiency and workflow for cardiac strain imaging procedures         
• In February 2024, Royal Philips announced the integration of artificial intelligence into its cardiac ultrasound devices and broader cardiac care offerings aimed at enhancing clinical confidence and operational efficiency. The Philips Ultrasound Compact System 5500 CV, a portable solution, now incorporates an AI-driven automation tool known as automated strain quantification. This tool aids in evaluating the left ventricle's function, a critical metric for assessing heart health
• In August 2023, Siemens Healthineers unveiled the Acuson Origin, a specialized cardiovascular ultrasound system featuring advanced artificial intelligence capabilities, during the annual meeting of the European Society of Cardiology (ESC)

Cardiovascular Ultrasound System Market Scope

The market is segmented on the basis of test type, technology, device display, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

• Transthoracic Echocardiogram
• Transoesophageal Echocardiogram
• Stress Echocardiogram
• Other Echocardiograms

Technology

• 2D Ultrasound
• 3D and 4D Ultrasound
• Doppler Imaging

Device Display

• Colour Display
• Black and White (B/W) Display

End-User

• Hospital and Cardiology Centres
• Home and Ambulatory Care Settings
• Research Institutes
• Medical Device, and Pharmaceutical Companies
• Other End Users

Cardiovascular Ultrasound System Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, test type, technology, device display, and end-user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to expanding preventive healthcare practices and the widespread adoption of advanced technologies. The region's robust healthcare infrastructure further accelerates market growth.                

L'Asie-Pacifique devrait connaître une croissance significative au cours de la période de prévision en raison de la prévalence croissante des maladies chroniques. Des politiques de remboursement et des cadres réglementaires favorables devraient également soutenir l'expansion du marché dans cette région au cours de la période de prévision. 

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.

Croissance de la base installée des infrastructures de santé et pénétration des nouvelles technologies

Le marché vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les biens d'équipement, la base installée de différents types de produits pour le marché, l'impact de la technologie à l'aide de courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché. Les données sont disponibles pour la période historique 2016-2021.

Analyse du paysage concurrentiel et des parts de marché des systèmes d'échographie cardiovasculaire

Le paysage concurrentiel du marché fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises par rapport au marché.

Certains des principaux acteurs opérant sur le marché sont :

• GE Healthcare (États-Unis)
• Koninklijke Philips NV (Pays-Bas)
• FUJIFILM Holdings Corporation (Japon)
• Siemens Healthineers AG (Allemagne)
• Hitachi Medical Corporation (Japon)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Chine)
• Samsung Electronics Co. Ltd. (Corée du Sud)
• Canon Medical Systems (Japon)
• Chison Medical Imaging Co. Ltd. (Chine)
• Esaote SPA (Italie)
• Kalamed GmbH Medical Systems (États-Unis)
• Unetixs Vascular, Inc. (États-Unis)

SKU-12915